Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections

Overview of attention for article published in Science Translational Medicine, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 88 news outlets
blogs: 3 blogs
twitter: 74 X users
patent: 2 patents
facebook: 9 Facebook pages

wikipedia: 1 Wikipedia page
googleplus: 2 Google+ users
reddit: 1 Redditor
f1000: 1 research highlight platform

Readers on

mendeley: 284 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 88 news stories from 88 outlets.

Aridis Meets Primary and Secondary Endpoints in Phase 2a Study of AR-501 in Cystic Fibrosis Patients

Jotup, 14 Mar 2023

LOS GATOS, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc.

Aridis Meets Primary and Secondary Endpoints in Phase 2a Study of AR-501 in Cystic Fibrosis Patients

Biz Wire Express, 13 Mar 2023

GlobeNewswire 2023-03-13 LOS GATOS, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Reports AR-501 Met Primary and Secondary Endpoints in Phase 2a Study

Investing.com, 13 Mar 2023

Aridis Pharmaceuticals, Inc. (Nasdaq: NASDAQ:) today announced preliminary top-line results from the randomized, double blinded…

Aridis Pharmaceuticals Reports AR-501 Met Primary and Secondary Endpoints in Phase 2a Study

Investing.com - UK, 13 Mar 2023

ARDS -0.76% Add to/Remove from a Portfolio Add to Watchlist Add Position Position added successfully to: + Add another position…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 84 additional news stories.